Section Arrow
INDV.NASDAQ
- Indivior PLC
Quotes are at least 15-min delayed:2025/11/16 06:45 EST
Regular Hours
Last
 30.49
+0.66 (+2.21%)
Day High 
30.865 
Prev. Close
29.83 
1-M High
32.4192 
Volume 
1.80M 
Bid
30.1
Ask
31.15
Day Low
29.39 
Open
29.87 
1-M Low
23.67 
Market Cap 
3.72B 
Currency USD 
P/E 30.44 
%Yield -- 
10-SMA 30.97 
20-SMA 28.1 
50-SMA 25.46 
52-W High 32.4192 
52-W Low 7.62 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.98/2.43
Enterprise Value
4.07B
Balance Sheet
Book Value Per Share
-1.66
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
1.09B
Operating Revenue Per Share
8.03
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.08-0.05-4.42%-- 
HIMSHims & Hers Health36.98+0.93+2.58%68.21PE
CGCCanopy Growth Corp1.07-0.03-2.73%-- 
AKBAAkebia Therapeutics1.67-0.09-5.11%-- 
AVDLAvadel Pharmaceuticals plc23.56+4.32+22.45%-- 
Quotes are at least 15-min delayed:2025/11/16 06:45 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.